‏إظهار الرسائل ذات التسميات D2R. إظهار كافة الرسائل
‏إظهار الرسائل ذات التسميات D2R. إظهار كافة الرسائل

Aparna Enterprises Launches Asia’s Largest Home Design Experiential Destination in Hyderabad

Aparna Enterprises Launches Asia’s Largest Home Design Experiential Destination in Hyderabad

Aparna Enterprises Ltd. (AEL), one of India’s fastest growing building materials manufacturers, has unveiled the Unispace Mega Store in Miyapur, Hyderabad, Asia’s largest experiential destination for home design and building solutions. Spanning 105,000 sq. ft. across two levels, this flagship store redefines the retail experience by offering an unparalleled range of categories under one roof. The launch marks a significant milestone in AEL’s retail expansion, adding to its growing network of Unispace showrooms in Jubilee Hills (Hyderabad), Bengaluru, Vijayawada.

The new Unispace destination brings together more than 20 categories of products and solutions, making it a one-stop platform for both B2B and B2C customers. It. represents a paradigm shift in how Indians design, build, and renovate their homes. Spread across two levels, the store features category-wise display zones including tiles and flooring, sanitaryware, bath fittings, modular kitchens, wardrobes, uPVC and aluminium windows + doors, electrical and lighting, appliances, construction materials, tools and machinery, outdoor furniture, landscaping solutions, and more.

A defining feature of the store is its immersive approach. Interactive zones, tech-enabled displays, and product demo areas have been created to enhance engagement, supported by a team of expert in-house design consultants. Customers can walk through fully functional apartment mock-ups, experience modular kitchens in action, and explore products through interactive digital displays. To strengthen industry connections, a dedicated events space has been built to host workshops, architect meets, and design seminars. For convenience, the store also houses a café, kids’ zone and EV charging stations.

The choice of Miyapur as the location highlights AEL’s forward-looking approach. With 150+ retail projects under development, excellent metro and ORR connectivity, and proximity to Hyderabad’s IT and industrial clusters, the store is strategically positioned to serve architects, designers, builders, and retail customers alike. With the building materials market in India projected to grow from USD 42.6 billion in 2024 to USD 64 billion by 2033, and globally at a CAGR of 6.2% from USD 929.8 billion in 2025 to USD 1,696.8 billion by 2035, this mega store is well-positioned to serve as a catalyst for the next phase of growth in housing, premium interiors, and sustainable construction.

Mr. Ashwin Reddy, Managing Director, Aparna Enterprises Ltd., “AEL’s transformation into a ₹2,000 crore enterprise has been driven by innovation, people-first practices, and heavy investment in R&D. The Miyapur flagship is a symbol of that journey, a place where international design meets Indian ingenuity. Our goal is not just to sell products but to deliver solutions built to last, enabling customers to design and build with confidence. This reflects our alignment with India’s aspiration to lead globally in quality, sustainability, and innovation.”

Ms. Aparna Reddy, Executive Director, Aparna Enterprises Ltd., “We are delighted to launch our 4th Unispace store, which is also the largest in India and among the biggest experiential destinations for home design and building solutions in Asia. As consumer choices evolve and buying habits shift, we wanted to create a space that offers everything under one roof — a place where customers can find inspiration, expert guidance, and world-class solutions to bring their vision to life. From premium Indian offerings to globally renowned products through our exclusive tie-ups, we have curated a portfolio that reflects both aspiration and trust. With this store, our aim is to redefine the way people experience and choose solutions for their homes”

Envisioned in alignment with the national Atmanirbhar Bharat and Make in India initiatives, the new flagship store emphasizes AEL’s belief in the strength of Indian products, supported by global technologies and local expertise. Backed by strong in-house R&D, the product portfolio is future-ready, durable, and sustainable, reflecting India’s growing role in global supply chains. By integrating global standards with Indian ingenuity, Aparna Enterprises is creating experiences that empower customers.

About Aparna Enterprises Ltd:

Aparna Enterprises Limited (AEL) is a part of the highly successful Aparna Group. Founded in the year 1990, AEL operates through a range of businesses in building material products, such as RMC (ready-mix concrete), uPVC windows and doors, floor and wall tiles, aluminium window and door systems and exterior façades, cold roll form products (steel reinforcements for uPVC windows and doors, cable trays, false ceiling channels) and elegant bath spaces and kitchens. Associated with several landmark projects for over 30 years, AEL is renowned for setting benchmarks in technology, research, design, and quality. Today, AEL is an acknowledged leader in providing specifiers, contractors, and stakeholders with a range of high-quality products manufactured to the highest standards. AEL can meet any specification criteria while ensuring full compliance with all protocols.

Laborate's Aqualab’s Direct-to-Retail Model Scales Fast: ₹100 Cr Achieved, ₹250 Cr in Sight

Laborate's Aqualab’s Direct-to-Retail Model Scales Fast: ₹100 Cr Achieved, ₹250 Cr in Sight

Aqualab, the Direct-to-Retail division of Laborate Pharmaceuticals India Ltd, has crossed the ₹100 crore revenue mark within three years of launch and now expects to touch ₹250 crore by FY 25–26. The growth has been driven by an expanding portfolio of over 800 SKUs and a network of 500+ retail stockists, with Tier-II and Tier-III markets contributing a rising share of sales.

Since its inception in 2022, the division has reported consistent year-on-year growth, moving from ₹76 crore in FY 2022–23 to ₹108 crore in FY 2023–24, Aqualab has focused on ensuring affordability and last-mile access, enabling its medicines to reach smaller towns alongside metropolitan centres.

“Crossing ₹100 crore in three years demonstrates how quickly the Direct-to-Retail model is scaling in India. We are now targeting ₹250 crore by FY 25–26, with non-metro markets expected to contribute 42% of incremental growth. Expanding therapeutic categories and strengthening last-mile delivery will remain our key focus areas,” said Arpit Bhatia, Managing Director, Laborate Pharmaceuticals.

Aqualab’s rise is in step with national priorities such as Make in India and the government’s PLI push to boost domestic pharma manufacturing. The retail pharmacy market, pegged at ₹18,700 crore in FY24, is projected to touch ₹31,200 crore by FY32, growing at a CAGR of 6.6% on the back of stronger generic penetration, greater health awareness, and organised distribution. Leveraging this momentum, Aqualab is preparing to expand into new categories, add facilities, adopt digital channels, and explore exports, consolidating its position in India’s retail pharma landscape.

Laborate’s WHO, GMP, and EU GMP-certified facilities have provided Aqualab with the infrastructure to scale rapidly while maintaining international quality standards. The company operates modern plants with advanced manufacturing and quality control systems, enabling compliance with stringent benchmarks. This foundation has not only supported Aqualab’s domestic expansion but also positions the division for potential export opportunities in the future.

About Laborate Pharmaceuticals

Laborate
Founded in 1985, Laborate 1 is one of the leading pharmaceutical companies in India, with capabilities in manufacturing, R&D, and global distribution. The company provides pharmaceutical products in therapeutic categories that include CVS, Diabetics, Pain Management, CNS, and other general categories, and has presence in 55 countries worldwide.

Laborate’s facilities are cGMP compliant with several regulatory agencies including WHO-GMP, and now EU-GMP compliance. With innovation, quality, and affordability as the cornerstones of its strategy, Laborate is able to provide drugs in both branded and contract manufacturing capacities, to its clients

Market Reports

Market Report & Surveys
IndianWeb2.com © all rights reserved